Status:

COMPLETED

The Canadian UnRuptured Endovascular Versus Surgery Trial (CURES)

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborating Sponsors:

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

University of Alberta

Conditions:

Intracranial Aneurysms

Eligibility:

All Genders

18+ years

Brief Summary

Purpose: Phase 1: (Pilot Phase) To compare the treatment efficacy of surgical clipping and endovascular coiling for unruptured intracranial aneurysms. To obtain better estimates of morbidity and mo...

Eligibility Criteria

Inclusion

  • Patients at least 18 years of age with at least 10 years of remaining life expectancy
  • At least one documented, intradural, saccular intracranial aneurysm
  • The patient and aneurysm are considered appropriate for either surgical or endovascular treatment by the treating team
  • Aneurysm size 3-25 mm

Exclusion

  • Patients with any intracranial hemorrhage, including SAH, within the previous 30 days
  • Lesion characteristics not readily suitable for either endovascular or surgical treatment, in the opinion of the physician(s) intending to treat the aneurysm
  • Multiple aneurysms, where the treatment plan includes both surgical clipping as well as endovascular coiling
  • Aneurysm anticipated (pre-operatively) to require proximal vessel occlusion, a bypass, or other flow-redirecting therapy (such as flow-diverting stents) as part of treatment plan
  • Patients with baseline mRS \>2
  • Patients with a single cavernous aneurysm
  • Patients with dissecting, fusiform, or mycotic aneurysms
  • Patients with AVM-associated aneurysms
  • Pregnant patients (randomization (and treatment) may be delayed until after delivery)
  • Patients with absolute contraindications to anaesthesia, endovascular treatment or administration of contrast material, including low-osmolarity agents or gadolinium
  • Patients unable to give informed consent

Key Trial Info

Start Date :

September 26 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2022

Estimated Enrollment :

291 Patients enrolled

Trial Details

Trial ID

NCT01139892

Start Date

September 26 2010

End Date

October 1 2022

Last Update

July 6 2023

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Centre hospitalier universitaire de Liège

Liège, Belgium

2

Foothills Medical Center

Calgary, Alberta, Canada, T2N 2T9

3

University of Alberta Hospital

Edmonton, Alberta, Canada, T6G 2B7

4

Ottawa Hospital

Ottawa, Ontario, Canada, K1H 8L6